Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 11 EP applications Andrew John Wright has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12713969

THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5

IPC classification:
A61K 38/17, C07K 14/47
Agent:
Andrew John Wright, Potter Clarkson LLP
Status:
PATENT GRANTED
EP12723063

DELIVERY OF COATED HYDROPHOBIC ACTIVE AGENT PARTICLES

IPC classification:
A61L 29/16, A61L 29/12, A61L 29/08, A61K 9/70, A61K 9/14
Agent:
Andrew John Wright, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12785744

DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS

IPC classification:
A61K 38/14
Agent:
Andrew John Wright, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP12729328

HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES

IPC classification:
A61K 38/28, A61K 9/72
Applicant:
MannKind Corporation
Agent:
Andrew John Wright, Potter Clarkson LLP
Status:
APPLICATION REFUSED
EP12728093

VACCINE ADJUVANT COMPOSITION COMPRISING INULIN PARTICLES

IPC classification:
A61K 39/39, A61K 39/29, A61K 39/205, A61K 39/145, A61K 31/715
Agent:
Andrew John Wright, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12841395

CODON SIGNATURE FOR NEUROMYELITIS OPTICA

IPC classification:
G01N 33/564
Agent:
Andrew John Wright, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP13188367

Oxidized cardiolipin as a novel pro-inflammatory factor

IPC classification:
A61K 39/00, A61K 38/00, A61K 31/00, G01N 33/564, A61P 29/00, A61P 25/00, A61P 9/00
Agent:
Andrew John Wright, Potter Clarkson LLP
Agent:
Budde Schou AS
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13702703

NANOPARTICLE FORMULATIONS WITH ENHANCED MUCOSAL PENETRATION

IPC classification:
A61K 47/48, A61K 9/51, A61P 11/00
Applicant:
Johns Hopkins University
Agent:
Andrew John Wright, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP13194715

Muc-1 cytoplasmic domain peptides as inhibitors of cancer

IPC classification:
A61K 38/17, C07K 14/47, C07K 7/64
Applicant:
Dana-Farber Cancer Institute, Inc.
Agent:
Andrew John Wright, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP13749197

METHOD AND SYSTEM FOR ELECTRO-ASSISTED HYDROGEN PRODUCTION FROM ORGANIC MATERIAL

IPC classification:
C25B 1/00, C12P 7/64, C12P 7/02, C12P 3/00, C12P 1/00, C12N 13/00, C12M 1/42
Agent:
Andrew John Wright, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP13845400

SOLID DOSAGE FORM

IPC classification:
A61K 9/26, A61K 9/20
Agent:
Andrew John Wright, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature